Eiji Sugaru

1.6k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Eiji Sugaru is a scholar working on Oncology, Nephrology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eiji Sugaru has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Nephrology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eiji Sugaru's work include Chronic Kidney Disease and Diabetes (6 papers), Adipose Tissue and Metabolism (4 papers) and Peptidase Inhibition and Analysis (4 papers). Eiji Sugaru is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Adipose Tissue and Metabolism (4 papers) and Peptidase Inhibition and Analysis (4 papers). Eiji Sugaru collaborates with scholars based in Japan, United States and United Kingdom. Eiji Sugaru's co-authors include Anthony W. Ferrante, Rudolf Zechner, Jason Lei, Guenter Haemmerle, Tsutomu Nakagawa, Mutsuo Taiji, Michiko Ono‐Kishino, Hiroshi Noguchi, Amrom E. Obstfeld and Constance Gayet and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Diabetes.

In The Last Decade

Eiji Sugaru

21 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

2010 562 citations Eiji Sugaru, Guenter Haemmerle et al. Journal of Clinical Investigation profile →

Peers

Eiji Sugaru

EPIDE

PHYSI

IMMUN

CMN

Monika Karczewska‐Kupczewska Poland

Koon‐Ho Chan Hong Kong

Keizo Kaneko Japan

Toshiyuki Maki Japan

Ken‐ichi Hamagami Japan

Gökhan S. Hotamisligil United States

Eunhee Kim United States

Byung Yong Rhim South Korea

Airu S. Chen United States

Christine Y. Christ-Roberts United States

Monika Karczewska‐Kupczewska Poland

Eiji Sugaru

339 ×0.6

EPIDE

459 ×0.8

PHYSI

98 ×0.3

IMMUN

507 ×2.1

56 ×0.4

CMN

Citations per year, relative to Eiji Sugaru Eiji Sugaru (= 1×) peers Monika Karczewska‐Kupczewska

Countries citing papers authored by Eiji Sugaru

Since Specialization

Citations

This map shows the geographic impact of Eiji Sugaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Sugaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Sugaru more than expected).

Fields of papers citing papers by Eiji Sugaru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Sugaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Sugaru. The network helps show where Eiji Sugaru may publish in the future.

Co-authorship network of co-authors of Eiji Sugaru

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Sugaru. A scholar is included among the top collaborators of Eiji Sugaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Sugaru. Eiji Sugaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishinaka, Anri, Kentaro Ohara, Eiji Sugaru, et al.. (2023). TRPV4 channels promote vascular permeability in retinal vascular disease. Experimental Eye Research. 228. 109405–109405. 10 indexed citations

Dovedi, Simon J., Amy L. Adlard, Yosuke Ota, et al.. (2016). Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy. Oncotarget. 7(13). 17035–17046. 25 indexed citations

Murata, Masashi, Simon J. Dovedi, Robert W. Wilkinson, et al.. (2015). TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice. Cancer Immunology Immunotherapy. 64(10). 1229–1239. 19 indexed citations

Kimura, Hidenori, Tomonori Kobayashi, Katsuya Uchiyama, et al.. (2014). Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: Use of a carboxylate prodrug to improve bioavailability. Bioorganic & Medicinal Chemistry. 23(4). 779–790. 13 indexed citations

Nishio, Yukihiro, Hidenori Kimura, Eiji Sugaru, et al.. (2011). 2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A. Bioorganic & Medicinal Chemistry. 19(18). 5490–5499. 17 indexed citations

Sugaru, Eiji, et al.. (2010). Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. Journal of Clinical Investigation. 120(10). 3466–3479. 562 indexed citations breakdown →

Nishio, Yukihiro, Hidenori Kimura, Eiji Sugaru, et al.. (2010). Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore. Bioorganic & Medicinal Chemistry Letters. 20(24). 7246–7249. 19 indexed citations

Furuta, Yoshikazu, M. Horiguchi, Eiji Sugaru, et al.. (2009). Chronic administration of DSP‐7238, a novel, potent, specific and substrate‐selective DPP IV inhibitor, improves glycaemic control and β ‐cell damage in diabetic mice. Diabetes Obesity and Metabolism. 12(5). 421–430. 15 indexed citations

Tsujimura, Tsuyoshi, Michiko Ono‐Kishino, Jun Nagamine, et al.. (2009). The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters. Biomedical Research. 30(3). 177–182. 1 indexed citations

10.

Tsujimura, Tsuyoshi, Jun Nagamine, Eiji Sugaru, et al.. (2009). Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats. Biological and Pharmaceutical Bulletin. 32(12). 1991–1996. 3 indexed citations

11.

Tsujimura, Tsuyoshi, Jun Nagamine, Eiji Sugaru, et al.. (2008). Chronic Administration of SMP-534 Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats. Nephron Experimental Nephrology. 110(4). e99–e108. 4 indexed citations

12.

Tsujimura, Tsuyoshi, Jun Nagamine, Eiji Sugaru, et al.. (2008). Author Index Vol. 110, 2008. Nephron Experimental Nephrology. 110(4). 109–e109. 1 indexed citations

13.

Sugaru, Eiji, Tsutomu Nakagawa, Michiko Ono‐Kishino, et al.. (2006). Amelioration of Established Diabetic Nephropathy by Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in <i>db/db</i> Mice. Nephron Experimental Nephrology. 105(2). e45–e52. 14 indexed citations

14.

Yamanaka, M., Atsushi Tsuchida, Tsutomu Nakagawa, et al.. (2006). Brain‐derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice. Diabetes Obesity and Metabolism. 9(1). 59–64. 68 indexed citations

15.

Sugaru, Eiji, Tsutomu Nakagawa, Michiko Ono‐Kishino, et al.. (2006). Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy. American Journal of Nephrology. 26(1). 50–58. 14 indexed citations

16.

Sugaru, Eiji, Tsutomu Nakagawa, Michiko Ono‐Kishino, et al.. (2005). SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabeticdb/dbmice. American Journal of Physiology-Renal Physiology. 290(4). F813–F820. 25 indexed citations

17.

Sugaru, Eiji, Kazuhiko Horigome, Teruhisa Tokunaga, et al.. (2005). SMP-534 inhibits TGF-β-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis. American Journal of Physiology-Renal Physiology. 289(5). F998–F1004. 23 indexed citations

18.

Nakagawa, Tsutomu, Michiko Ono‐Kishino, Eiji Sugaru, et al.. (2002). Brain‐derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Diabetes/Metabolism Research and Reviews. 18(3). 185–191. 96 indexed citations

19.

Tsuchida, Atsushi, Takeshi Nonomura, Tsutomu Nakagawa, et al.. (2002). Brain‐derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Diabetes Obesity and Metabolism. 4(4). 262–269. 82 indexed citations

20.

Nagao, Masaya, Eiji Sugaru, Taiho Kambe, & Ryuzo Sasaki. (1999). Unidirectional Transport from Apical to Basolateral Compartment of Cobalt Ion in Polarized Madin-Darby Canine Kidney Cells. Biochemical and Biophysical Research Communications. 257(2). 289–294. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact